• Press Release

American College of Cardiology 46th New York Cardiovascular Symposium December 13-15 Led by Dr. Valentin Fuster

As one of the most prestigious cardiology events in the world, it will review and highlight latest advances in cardiology in 2013 and the next big things in 2014.

  • (December 09, 2013)

More than 2,000 experts in the field of cardiology will join together at this year's three-day American College of Cardiology 46th New York Cardiovascular Symposium from December 13-15 in New York City. The event, which is one of the most prestigious cardiology events in the world, will review and highlight the latest advances in cardiology for 2013 and the next big things to expect in cardiology in 2014.

The annual, highly anticipated New York Cardiovascular Symposium is hosted and directed by Valentin Fuster, MD, PHD, MACC, a global leader in cardiovascular medicine for the last three decades who serves as Director of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital. Dr. Fuster, the next Editor-in-Chief of the Journal of the American College of Cardiology (JACC) in 2014, has directed the Symposium for the last 20 years.

The event, hosted at the New York Hilton-Midtown, will include presentations by Dr. Fuster and 40 other leading cardiac experts from premier cardiac institutions across the country. They will discuss and debate the latest timely and major questions, topics, challenges, and breakthrough advances in the field of cardiovascular medicine today and what lies ahead for tomorrow. The large audience will include cardiologists, cardiac interventionalists, electrophysiologists, cardiac surgeons, nurses, and other healthcare professionals.

The three-day Symposium led by Dr. Fuster will be kicked-off the morning of Friday, December 13 at 7:15am by Shalom “Shal” Jacobovitz, Chief Executive Officer, American College of Cardiology; John G. Harold, MD, MACC, President, American College of Cardiology; and Smadar Kort, MD, FACC, Governor, American College of Cardiology, Downstate New York.

This year's agenda for the New York Cardiovascular Symposium will focus on the evolution of cardiology in 2013 and what to expect in 2014. Key presentation highlights include:

Friday, Dec. 13
Chaired by Dr. Christopher P. Cannon, Brigham and Women's Hospital and Harvard Medical School

  • Predictive value of the subclinical atherosclerosis burden: Future use of carotid 3D ultrasound plus coronary calcium score (Dr. Valentin Fuster, Mount Sinai Hospital)
  • Predictive value of proteomics and genomics in coronary artery disease and evolving pharmacological options (Dr. Patrick T. O'Gara, Brigham and Women's Hospital and Harvard Medical School)

Chaired by Dr. Lars Wallentin, Uppsala Clinical Research Center

  • The science of stents in acute coronary syndrome, based on the 2012-2013 data
  • The view of the interventionalist (Dr. Samin Sharma, Mount Sinai Hospital)
  • The view of the pathologist (Dr. Renu Virmani, CVPath Institute, Inc.)

Chaired by Dr. Sidney C. Smith, Jr., University of North Carolina School of Medicine

  • New guidelines on lipids: Are PCsK 9 inhibitors poised for breakthrough? (Dr. Sidney C. Smith, Jr.)
  • New guidelines on hypertension: New approaches from population salt reduction to personalized treatment targets (Dr. Donna Arnett, University of Alabama Birmingham School of Public Health)
  • Renal sympathetic denervation: Is this a real long term breakthrough? (Dr. Mark W. Burket, University of Toledo Medical Center)
  • Diabetes and contemporary targets: Are we ready for bariatric surgery? (Dr. David M. Nathan, Massachusetts General Hospital and Harvard Medical School
  • Promoting cardiovascular health challenges: Pre-school children, the adult community, the elderly, and the polypill (Dr. Valentin Fuster, Mount Sinai Hospital)

Saturday, Dec. 14
Chaired by Dr. Clyde W. Yancy, Northwestern University Feinberg School of Medicine

  • Diagnostic and prognostic imaging using MR and CT for cardiomyopathies, other heart muscle related issues, and the management of heart failure (Dr. Henry R. Halperin, Johns Hopkins University School of Medicine)
  • Rapid evolving alternative to heart transplants, LVADS for destination therapy to close the heart transplant gap (Dr. Donna M. Mancini, NewYork-Presbyterian Hospital/Columbia University Medical Center)

Chaired by Dr. Francis E. Marchlinski, Hospital of the University of Pennsylvania

  • Arrhythmia disorders: latest devices, and therapies such as catheter ablation and left atrial appendage closure, improving quality of life and preventing strokes (Dr. Michael R. Gold, Medical University of South Carolina; Dr. Francis E. Marchlinski, Hospital of the University of Pennsylvania; Dr. Valentin Fuster and Dr. Vivek Reddy, The Mount Sinai Hospital)

Chaired by Dr. Robert O. Bonow, Northwestern University Feinberg School of Medicine

  • Aortic stenosis challenges in evaluation and management, and interventional decision-making considering patient age and the use of prosthetic valves (Dr. Robert O. Bonow; Dr. Paul Stelzer, Dr. David H. Adams, and Dr. Samin Sharma of Mount Sinai Hospital)
  • Debating future management of mitral regurgitation: Operate earlier (Dr. Robert O. Bonow), almost 100% should be repair (Dr. David H. Adams, Mount Sinai Hospital), and the future role of the cardiac interventionalist (Dr. Ted Feldman, Evanston Hospital)

Sunday, Dec. 15
Novelties on genetics, cell regeneration, and molecular signaling
Chaired by Dr. Valentin Fuster, Mount Sinai Hospital

  • New findings on the embryogenic development of the heart and implications for stem cell regeneration in adult myocardium (Dr. Miguel Torres, CNIC in Spain)
  • New therapeutic findings on LV dysfunction and the viable myocardium: A therapeutic upgrade of metabolism by gene therapy (Dr. Roger Hajjar, Mount Sinai Hospital)
  • New therapeutic findings on LV dysfunction to the scarred myocardium: A response to islet progenitor cells and paracrine factors (Dr. Piero Anversa, Brigham and Women's Hospital and Harvard Medical School)

Novelties on diagnostic and therapeutic strategies (8:55am-9:55am)
Chaired by Dr. Valentin Fuster, Mount Sinai Hospital

  • Advances and future directions of imaging in myocardial disease identification and management (Dr. Jagat Narula, Mount Sinai Hospital)
  • The high investigational value of the coronary atherosclerotic plaque: The evolving role of OCT, optical coherence tomography (Dr. Ik-Kyung Jang, Massachusetts General and Harvard Medical School)

THE NEXT BIG THINGS (10:15am-11:30am)
Chaired by Dr. Valentin Fuster, Mount Sinai Hospital

The next big things in cardiology:

  • Renal denervation therapy for arrhythmias and for autonomic nervous system dysfunction (Dr. Vivek Reddy, Mount Sinai Hospital)
  • Stroke (Dr. Ralph L. Sacco, University of Miami Miller School of Medicine)
  • Promoting health (Dr. Valentin Fuster, Mount Sinai Hospital)

The full agenda for the American College of Cardiology 46th New York Cardiovascular Symposium is available, here.

About the Mount Sinai Health System

The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services—from community-based facilities to tertiary and quaternary care.

The System includes approximately 7,100 primary and specialty care physicians; 12 joint-venture ambulatory surgery centers; more than 140 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. Physicians are affiliated with the renowned Icahn School of Medicine at Mount Sinai, which is ranked among the highest in the nation in National Institutes of Health funding per investigator. The Mount Sinai Hospital is in the "Honor Roll" of best hospitals in America, ranked No. 15 nationally in the 2016-2017 "Best Hospitals" issue of U.S. News & World Report. The Mount Sinai Hospital is also ranked as one of the nation's top 20 hospitals in Geriatrics, Gastroenterology/GI Surgery, Cardiology/Heart Surgery, Diabetes/Endocrinology, Nephrology, Neurology/Neurosurgery, and Ear, Nose & Throat, and is in the top 50 in four other specialties. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 10 nationally for Ophthalmology, while Mount Sinai Beth Israel, Mount Sinai St. Luke's, and Mount Sinai West are ranked regionally. Mount Sinai's Kravis Children's Hospital is ranked in seven out of ten pediatric specialties by U.S. News & World Report in "Best Children's Hospitals."

For more information, visit http://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.